Pieris Pharmaceuticals Operating Income 2014-2024 | PVLA

Pieris Pharmaceuticals operating income from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Pieris Pharmaceuticals Operating Income 2014-2024 | PVLA

Pieris Pharmaceuticals operating income from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
NPK (NPKI)$626M
Performant Healthcare (PHLT)$245M
FTAC Emerald Acquisition (FLDD)$158M
Swiftmerge Acquisition (ANNA)$42M
Insight Acquisition (AMOD)$23M
Hanryu Holdings (GITS)$17M
LQR House (YHC)$11M
ATIF Holdings (ZBAI)$9M
Lion Electric (LEVGQ)$0M